Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Therapy

Background:

• Nucleoside kinase suicide gene therapy relies on bystander cell killing for efficacy.
• Mitochondrial nucleoside kinases are being explored as potential suicide genes.
• Bystander killing involves the transfer of cytotoxic phosphorylated nucleoside analogs to adjacent cells.

Purpose of the Study:

• To investigate whether nucleoside analogs phosphorylated in the mitochondrial matrix can induce bystander cell killing.
• To compare the bystander effect of nucleoside analogs phosphorylated in the cytosol versus the mitochondrial matrix.

Main Methods:

• Utilized deoxycytidine kinase-deficient Chinese hamster ovary cells.
• Reconstituted cells with deoxycytidine kinase targeted to either the cytosol or mitochondrial matrix.
• Incubated cells with nucleoside analogs 1-beta-D-arabinofuranosylcytosine and 2",2"-difluorodeoxycytidine to assess bystander cell killing.

Main Results:

• A bystander effect was observed when nucleoside analogs were phosphorylated in the cytosol.
• No significant bystander effect was detected when nucleoside analogs were phosphorylated within the mitochondrial matrix.
• Mitochondrial targeting of nucleoside kinases did not promote the necessary cell-to-cell killing.

Conclusions:

• Nucleoside kinases targeted to the mitochondrial matrix are unlikely to be effective for suicide gene therapy requiring substantial bystander cell killing.
• Cytosolic phosphorylation of nucleoside analogs is essential for mediating the bystander effect in this context.
• These findings limit the application of mitochondrial nucleoside kinases in cancer suicide gene therapy strategies focused on bystander effects.